Kuehne+Nagel and Medtronic open healthcare fulfilment centre in Milton, Canada
Kuehne+Nagel, one of the world’s leading logistics companies, announced the opening of a new, temperature-controlled fulfilment centre for its partner, Medtronic. The global healthcare technology company develops, manufactures, and sells medical devices and therapies to treat complex medical conditions.
At the 25,000 sqm site, Kuehne+Nagel supports Medtronic by distributing its products to hospitals and institutions. Medtronic also operates a service and repair centre within the facility, as well as a test and preventative maintenance centre for their medical equipment.
This partnership combines the technical, operational, and engineering expertise of Kuehne+Nagel and Medtronic, to meet the increasing demand for healthcare logistics and serving the urgent needs of patients and the healthcare community.
“The partnership between Kuehne+Nagel and Medtronic underscores the trust and confidence placed in Kuehne+Nagel's capabilities and our commitment to delivering high-quality and reliable logistics services for Medtronic’s critical medical device products,” said Eduardo Razuck, Head of Contract Logistics, Americas, Kuehne+Nagel. "In Kuehne+Nagel’s Roadmap 2026, healthcare is identified as a key growth area, where we are committed to further invest in order to make a positive impact on patients’ lives."
“We are proud to partner with Kuehne+Nagel, who we trust to address the unique challenges we face in healthcare supply chain while maintaining our highest quality standards and regulatory compliance to best meet the needs of our customers and the patients we serve,” said Mbaye Seye, Operations Manager, Medtronic. “Our culture and values align with Kuehne+Nagel as we collectively focus on the critical importance of always putting patients first.”
In the last decade, the healthcare market in Canada has grown due to technological advancements, changing demographics and healthcare investments, particularly in a post-pandemic environment. According to research, the medical device market is projected to grow at a compound annual growth rate of 5.8% from 2024 to 2030 and within the pharmaceuticals sector, market demand continues to drive impressive growth. With a strategic focus on expanding its presence in North America, Kuehne+Nagel is committed to providing exceptional service to customers in the pharmaceuticals, medical devices, and other healthcare consumer product markets.